Citation: Pk. Mukherjee et al., Reintroduction of the PLB1 gene into Candida albicans restores virulence in vivo, MICROBI-SGM, 147, 2001, pp. 2585-2597
Authors:
Hawser, SP
Jessup, C
Vitullo, J
Ghannoum, MA
Citation: Sp. Hawser et al., Utility of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT) and minimum effective concentration assays in the determination of antifungal susceptibility of Aspergillus fumigatus to the lipopeptide class of compounds, J CLIN MICR, 39(7), 2001, pp. 2738-2741
Authors:
Gottfredsson, M
Jessup, CJ
Cox, GM
Perfect, JR
Ghannoum, MA
Citation: M. Gottfredsson et al., Fungal phospholipase activity and susceptibility to lipid preparations of amphotericin B, ANTIM AG CH, 45(11), 2001, pp. 3231-3233
Authors:
Chandra, J
Kuhn, DM
Mukherjee, PK
Hoyer, LL
McCormick, T
Ghannoum, MA
Citation: J. Chandra et al., Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance, J BACT, 183(18), 2001, pp. 5385-5394
Authors:
Liu, LM
Kang, KF
Takahara, M
Cooper, KD
Ghannoum, MA
Citation: Lm. Liu et al., Hyphae and yeasts of Candida albicans differentially regulate interleukin-12 production by human blood monocytes: Inhibitory role of C-albicans germination, INFEC IMMUN, 69(7), 2001, pp. 4695-4697
Citation: Ma. Hossain et Ma. Ghannoum, New investigational antifungal agents for treating invasive fungal infections, EXPERT OP I, 9(8), 2000, pp. 1797-1813
Authors:
Ghannoum, MA
Hajjeh, RA
Scher, R
Konnikov, N
Gupta, AK
Summerbell, R
Sullivan, S
Daniel, R
Krusinski, P
Fleckman, P
Rich, P
Odom, R
Aly, R
Pariser, D
Zaiac, M
Rebell, G
Lesher, J
Gerlach, B
Ponce-de-Leon, GF
Ghannoum, A
Warner, J
Isham, N
Elewski, B
Citation: Ma. Ghannoum et al., A large-scale North American study of fungal isolates from nails: The frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns, J AM ACAD D, 43(4), 2000, pp. 641-648
Authors:
Barry, AL
Pfaller, MA
Brown, SD
Espinel-Ingroff, A
Ghannoum, MA
Knapp, C
Rennie, RP
Rex, JH
Rinaldi, MG
Citation: Al. Barry et al., Quality control limits for broth microdilution susceptibility tests of tenantifungal agents, J CLIN MICR, 38(9), 2000, pp. 3457-3459
Authors:
Jessup, CJ
Warner, J
Isham, N
Hasan, I
Ghannoum, MA
Citation: Cj. Jessup et al., Antifungal susceptibility testing of dermatophytes: Establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates, J CLIN MICR, 38(1), 2000, pp. 341-344
Authors:
Ghannoum, MA
Okogbule-Wonodi, I
Bhat, N
Sanati, H
Citation: Ma. Ghannoum et al., Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model, J CHEMOTHER, 11(1), 1999, pp. 34-39
Citation: Ma. Ghannoum et B. Elewski, Successful treatment of fluconazole-resistant oropharyngeal candidiasis bya combination of fluconazole and terbinafine, CL DIAG LAB, 6(6), 1999, pp. 921-923
Authors:
Bradley, MC
Leidich, S
Isham, N
Elewski, BE
Ghannoum, MA
Citation: Mc. Bradley et al., Antifungal susceptibilities and genetic relatedness of serial Trichophytonrubrum isolates from patients with onychomycosis of the toenail, MYCOSES, 42, 1999, pp. 105-110
Citation: Ma. Ghannoum et Lb. Rice, Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance, CLIN MICROB, 12(4), 1999, pp. 501
Authors:
Powderly, WG
Gallant, JE
Ghannoum, MA
Mayer, KH
Navarro, EE
Perfect, JR
Citation: Wg. Powderly et al., Oropharyngeal candidiasis in patients with HIV: Suggested guidelines for therapy, AIDS RES H, 15(18), 1999, pp. 1619-1623
Citation: Ha. Norris et al., Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method, J AM ACAD D, 40(6), 1999, pp. S9-S13